Биологическая активность
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 моноклональный антитело (MAb). Mogamulizumab can eliminate tumor cells by антитело-dependent клеточный cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-клетка leukemia/lymphoma (ATLL), cutaneous T-клетка lymphoma (CTCL).
Оригинал на английском
Mogamulizumab (KW-0761) is a recombinant anti-CCR4 monoclonal antibody (MAb). Mogamulizumab can eliminate tumor cells by antibody-dependent cellular cytotoxicity (ADCC). Mogamulizumab can be used in the research of cancers, adult T-cell leukemia/lymphoma (ATLL), cutaneous T-cell lymphoma (CTCL).
Химические свойства
- CAS №
- 1159266-37-1 pH value: Corresponds to reference standard: PASS Non-reduced CE-SDS: >95% SEC-HPLC: >95% Isoelectric Point: Corresponds to reference standard Osmolality: Corresponds to reference standard: PASS Peptide mapping: Corresponds to reference standard: PASS N-terminal sequence: Corresponds to reference standard: PASS
Безопасность и документация
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.